Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Daiichi Sankyo
US Department of Justice

Generated: November 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 064153

« Back to Dashboard

NDA 064153 describes BACIIM, which is a drug marketed by X Gen Pharms and is included in one NDA. It is available from one supplier. Additional details are available on the BACIIM profile page.

The generic ingredient in BACIIM is bacitracin. There are twenty-seven drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the bacitracin profile page.
Summary for 064153
Applicant:X Gen Pharms
Formulation / Manufacturing:see details
Pharmacology for NDA: 064153
Medical Subject Heading (MeSH) Categories for 064153
Suppliers and Packaging for NDA: 064153
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
BACIIM bacitracin INJECTABLE;INJECTION 064153 ANDA X-GEN Pharmaceuticals, Inc. 39822-0277 39822-0277-5 10 VIAL in 1 CARTON (39822-0277-5) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL (39822-0277-2)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength50,000 UNITS/VIAL
Approval Date:May 9, 1997TE:APRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:


Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.